Moshe "Mori" Arkin (Hebrew: משה "מורי" ארקין; born 1952/53) is an Israeli billionaire businessman, the founder and chairman of Arkin Holdings, a pharmaceutical company.[2]
Mori Arkin | |
|---|---|
| Born | 1952 or 1953 (age 71–72)[1] |
| Nationality | Israeli |
| Alma mater | Tel Aviv University |
| Occupation | businessman |
| Spouse | married |
| Children | 3 |
Early life
editMori Arkin is the son of Ziama Arkin, who died in 1972, when Mori was 19.[3] Arkin has a degree in psychology and philosophy from Tel Aviv University.[4]
Career
editIn 1961, his father Ziama Arkin founded Agis Industries, an Israeli pharmaceutical importer.[3] Agis grew into a generic pharmaceutical manufacturer, and in 2005, Mori Arkin sold Agis to Perrigo for $390 million.[2]
Arkin is the founder and chairman of Arkin Holdings, a pharmaceutical company. He is the co-founder and chairman of the Accelmed Fund.[5]
Personal life
editArkin is married with three children, and lives in Herzliya Pituah, Israel.[1]
References
edit- ^ a b "Mori Arkin". Forbes. Retrieved 13 January 2017.
- ^ a b "Pharma Kingpin-Turned-VC Mori Arkin Joins Billionaires' Club". Forbes.com. 2012-12-18. Retrieved 2017-01-13.
- ^ a b "About". Arkin Holdings. 2014-06-20. Retrieved 2017-01-13.
- ^ "Our Team". Arkin Holdings. 2014-06-20. Retrieved 2017-01-13.
- ^ Moshe Arkin. "Moshe Arkin: Executive Profile & Biography". Bloomberg. Retrieved 2017-01-13.